Laurus Labs has informed about the launch of the generic version of Lyrica®, (pregabalin) Capsules, in all eight commercially available strengths (25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, & 300 mg) in US market along with its exclusive distribution partner Rising Pharmaceuticals, a Rising Pharma Holdings Inc. company. Rising recently received the final approval from the US Food and Drug Administration (FDA) for the Abbreviated New Drug Application (ANDA). A press release to this extent is also attached.
\The above information is a part of company’s filings submitted to BSE.
